Cipla Limited has informed the Exchange regarding a press release dated September 03, 2026, titled ""Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytrudar (Pembrolizumab) in the US"".
FILING COMPLAINTS ON SCORES - EASY & QUICK a. Register on SCORES portal b. Mandatory details for filing complaints on SCORES: i. Name, PAN, Address, Mobile Number, E-mail ID c. Benefits: i. Effective communication ii. Speedy redressal of the grievances SEBI : https://scores.sebi.gov.in